Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(21)
PROCEDURE(5)
DRUG(4)
OTHER(1)
Magnetic Resonance Imaging
2 trials
phase_2phase_3
national-cancer-institute-nci
fluorouracil
2 trials
phase_1_2phase_2
eastern-cooperative-oncology-group, national-cancer-institute-nci
leucovorin calcium
2 trials
phase_1_2phase_2
eastern-cooperative-oncology-group, national-cancer-institute-nci
Computed Tomography
2 trials
phase_2phase_3
national-cancer-institute-nci
oxaliplatin
2 trials
phase_1_2phase_2
national-cancer-institute-nci, eastern-cooperative-oncology-group
Biospecimen Collection
2 trials
phase_2phase_3
national-cancer-institute-nci
Patient Observation
1 trial
phase_3
national-cancer-institute-nci
High Resolution Anoscopy
1 trial
phase_3
national-cancer-institute-nci

+17 more interventions

25 unique interventions4 categories

Analytics

Trial Phases

Phase 11
Phase 23
Phase 31

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05836584Phase 2Active Not Recruiting
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
Clinical Stage I Gastric Cancer AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8+7 more
PrincipalinvestigatorStart date: 2023-12-06
NCT03233711Phase 3Active Not Recruiting
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more
PrincipalinvestigatorStart date: 2018-07-05
NCT02893930Phase 2Completed
Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery
Pancreatic Neuroendocrine Tumor G1Pancreatic Neuroendocrine Tumor G2Refractory Pancreatic Neuroendocrine Carcinoma
PrincipalinvestigatorStart date: 2017-04-28
NCT02344810Phase 1/2Withdrawn
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Virginia Sun

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage IIIA Gastric CancerStage IIIB Gastric CancerStage IIIC Gastric Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

jiafu ji, MD

Peking University Cancer Hospital & Institute

Related
7 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score2%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score2%

lin shen, Professor

Peking University Cancer Hospital & Institute

Related
10 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score2%

Yelena Janjigian, MD

Memorial Sloan Kettering Cancer Center

Related
12 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score2%

Manish Shah, MD

Weill Medical College of Cornell University

Related
7 trials

Shared therapeutic areas:

Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Lin Shen, PhD

Peking University Cancer Hospital & Institute

Related
10 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score2%

Zhaohui Zhu

Peking Union Medical College Hospital

Related
7 trials

Shared therapeutic areas:

Cancer of Gastrointestinal Tract
Similarity Score1%

James C Yang, M.D.

National Cancer Institute (NCI)

Related
7 trials

Shared therapeutic areas:

Cancer of Gastrointestinal Tract

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05836584Phase 2PrincipalInvestigator

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Clinical Stage I Gastric Cancer AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8+7 more
Active Not Recruiting
NCT03233711Phase 3PrincipalInvestigator

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more
Active Not Recruiting
NCT02893930Phase 2PrincipalInvestigator

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Pancreatic Neuroendocrine Tumor G1Pancreatic Neuroendocrine Tumor G2Refractory Pancreatic Neuroendocrine Carcinoma
Completed
NCT02344810Phase 1/2PrincipalInvestigator

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Withdrawn

All 4 trials loaded